These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 16463553)
61. EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis. Palacios S; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S Maturitas; 2012 Feb; 71(2):194-8. PubMed ID: 22176952 [TBL] [Abstract][Full Text] [Related]
62. Ask the doctor. I've had osteoporosis for several years, and I've been taking alendronate (Fosamax) once a week. I wasn't very good at remembering to take it regularly, so my doctor recently recommended that I start on once-a-year infusions of zoledronic acid (Reclast). Will it work as well to prevent me from breaking a bone? Fabiny A Harv Womens Health Watch; 2014 Apr; 21(8):2. PubMed ID: 25097938 [No Abstract] [Full Text] [Related]
63. Bisphosphonates and glucocorticoids: effects on bone quality. Lems WF Arthritis Rheum; 2007 Nov; 56(11):3518-22. PubMed ID: 17968935 [No Abstract] [Full Text] [Related]
73. Once-monthly oral ibandronate treatment in an adolescent with recurrent fractures and inadequately low bone mass. Kutilek S; Plasilová I; Nemec V J Paediatr Child Health; 2012 Jul; 48(7):622-3. PubMed ID: 22758903 [No Abstract] [Full Text] [Related]
74. Bone health medications: research questions versus clinical choices. Goldstein SR Menopause; 2011 Aug; 18(8):835-6. PubMed ID: 21785375 [No Abstract] [Full Text] [Related]
75. Placebo-controlled trials in osteoporosis--proceeding with caution. Rosen CJ; Khosla S N Engl J Med; 2010 Sep; 363(14):1365-7; discussion e22. PubMed ID: 20879887 [TBL] [Abstract][Full Text] [Related]
76. Bridging the gap between evidence and practice in osteoporosis. Hansen LB Am J Health Syst Pharm; 2008 Feb; 65(4):297. PubMed ID: 18238766 [No Abstract] [Full Text] [Related]
78. Bisphosphonates and colon cancer: reply. Pazianas M; Abrahamsen B; Eiken PA; Eastell R; Russell RG Osteoporos Int; 2013 Mar; 24(3):1141-2. PubMed ID: 22847317 [No Abstract] [Full Text] [Related]
79. Bone diseases: bisphosphonates in osteoporosis--beyond 5 years. Papapoulos SE Nat Rev Rheumatol; 2013 May; 9(5):263-4. PubMed ID: 23591488 [No Abstract] [Full Text] [Related]
80. Did prescription bias affect outcomes in a study of the relative effectiveness of osteoporosis drugs? Beri A; Khattri S Ann Intern Med; 2008 Oct; 149(7):514; author reply 514. PubMed ID: 18838735 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]